Bright minds announces effective date of share consolidation

Vancouver, british columbia, july 11, 2023 (globe newswire) -- bright minds biosciences inc. (cse: drug) (nasdaq: drug) (“bright minds” or the “company”), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, announces that, further to its news release on june 22, 2023, the company will consolidate its common shares (the “common shares”) on a five (5) to one (1) basis (the “consolidation”).
DRUG Ratings Summary
DRUG Quant Ranking